Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06299345
Other study ID # 1870394-1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2022
Est. completion date April 28, 2022

Study information

Verified date March 2024
Source Kafrelsheikh University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare the effects of different durations of Motor Imagery (MI) practice and physical practice on motor performance enhancement in healthy adults. The main questions it aims to answer are: - Does Motor Imagery (MI) practice improve motor performance? - How do different doses of MI practice (low vs. high) compare to no MI practice in enhancing motor performance? Participants: - Be randomly assigned to one of three groups: no MI practice (control group), low dose MI practice (6 minutes per session), or high dose MI practice (12 minutes per session). - Complete nine sessions over three weeks, practicing a timed mirror tracing task. - Have their performance measured in each session by the time taken to complete the task and the number of errors made. Compared the control group, low dose MI group, and high dose MI group to see if there are significant differences in motor performance enhancement, aiming to determine the effectiveness of MI and the optimal dose for practice.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date April 28, 2022
Est. primary completion date April 20, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - no history of motor dysfunction, coordination disorders, or surgical procedures in the past 6 months - scored 4 or less on the Movement Imagery Questionnaire (MIQ) on the non-dominant hand. Exclusion Criteria: - Played the target task in the past 6 months - Subjects were ambidextrous

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Motor imagery training
MI for this study took the form of non-guided first-person mental practice. First-person imagery was explained to each participant where they imagined performing the target skill through their own eyes rather than if they were a bystander watching someone else do the task (third person).
NO motor imagery training
The participants performed the physical task only. It is a mirror tracing game that requires participants to trace a star shape viewed through a mirror, going as fast as possible while staying within the lines.

Locations

Country Name City State
Egypt Kafrelshaikh University Kafr Ash Shaykh
United States Concordia University Wisconsin Mequon Wisconsin

Sponsors (2)

Lead Sponsor Collaborator
Ahmed Mahmoud Kadry Concordia University Wisconsin

Countries where clinical trial is conducted

United States,  Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time The time to complete the physical tracing task was measured from when the investigator said 'GO' until the participant returned the pen to the starting point. The physical tracing task is a mirror tracing game that requires participants to trace a star shape viewed through a mirror, going as fast as possible while staying within the lines. Time was measured at the end of each session, with intervals of 3 session/week for 3 weeks with total of 9 sessions. So, the research ended up with 9 reading for the time.
Primary Errors Errors were operationally defined as each time the pen went outside of the shape lines while doing the physical tracing task. Crossing a line and returning to the original trace was counted as one error. Errors were counted by the number of times the pen went outside the lines. Errors were counted at the end of each session, with intervals of 3 session/week for 3 weeks with total of 9 sessions. So, the research ended up with 9 reading for the time.
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1